Clinical data | |
---|---|
Other names | beta-Dihydroergocryptine |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.039.157 |
Chemical and physical data | |
Formula | C32H43N5O5 |
Molar mass | 577.726 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Epicriptine or beta-dihydroergocryptine is a dopamine agonist of the ergoline class. It constitutes one third of the mixture known as dihydroergocryptine, the other two thirds consisting of alpha-dihydroergocryptine. The alpha differs from the beta form only in the position of a single methyl group, which is a consequence of the biosynthesis in which the proteinogenic amino acid isoleucine is replaced by leucine.
References
- Steinhilber D, Schubert-Zsilavecz M, Roth HJ (2005). Medizinische Chemie (in German). Stuttgart: Deutscher Apotheker Verlag. p. 142. ISBN 3-7692-3483-9.
Ergolines | |
---|---|
Lysergic acid derivatives |
|
Psychedelic lysergamides |
|
Clavines | |
Other ergolines | |
Related compounds | |
Natural sources |
Morning glory: Argyreia nervosa (Hawaiian Baby Woodrose), Ipomoea spp.(Morning Glory, Tlitliltzin, Badoh Negro), Rivea corymbosa (Coaxihuitl, Ololiúqui) |
This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |